Immunogenicity to biological drugs in psoriasis and psoriatic arthritis.

Clinics (Sao Paulo) · 2021 · PMC8449932 · PMID 34614113

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

Overall, the incidence of potential immunogenicity-related AEs did not show a clear trend in patients with inconclusive titers or in any category of ADA-positive patients, compared to patients without ADA, similar to other results with anti-IL-23/IL-17 biologics ( 78 ).

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.